These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 23075629

  • 1. Literature review of recombinant tissue plasminogen activator used for recent-onset submacular hemorrhage displacement in age-related macular degeneration.
    van Zeeburg EJ, van Meurs JC.
    Ophthalmologica; 2013; 229(1):1-14. PubMed ID: 23075629
    [Abstract] [Full Text] [Related]

  • 2. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
    Treumer F, Wienand S, Purtskhvanidze K, Roider J, Hillenkamp J.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
    [Abstract] [Full Text] [Related]

  • 3. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
    Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC.
    Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972
    [Abstract] [Full Text] [Related]

  • 4. Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration.
    Guthoff R, Guthoff T, Meigen T, Goebel W.
    Retina; 2011 Jan; 31(1):36-40. PubMed ID: 20921929
    [Abstract] [Full Text] [Related]

  • 5. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.
    Treumer F, Roider J, Hillenkamp J.
    Br J Ophthalmol; 2012 May; 96(5):708-13. PubMed ID: 22174095
    [Abstract] [Full Text] [Related]

  • 6. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.
    Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG.
    Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):5-11. PubMed ID: 19669780
    [Abstract] [Full Text] [Related]

  • 7. INTRAVITREAL VERSUS SUBRETINAL ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR COMBINED WITH GAS FOR ACUTE SUBMACULAR HEMORRHAGES DUE TO AGE-RELATED MACULAR DEGENERATION: An Exploratory Prospective Study.
    de Jong JH, van Zeeburg EJ, Cereda MG, van Velthoven ME, Faridpooya K, Vermeer KA, van Meurs JC.
    Retina; 2016 May; 36(5):914-25. PubMed ID: 26807631
    [Abstract] [Full Text] [Related]

  • 8. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas.
    Hesse L, Schmidt J, Kroll P.
    Graefes Arch Clin Exp Ophthalmol; 1999 Apr; 237(4):273-7. PubMed ID: 10208258
    [Abstract] [Full Text] [Related]

  • 9. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
    Auriol S, Mahieu L, Lequeux L, Quintyn JC, Pagot-Mathis V.
    J Fr Ophtalmol; 2010 Feb; 33(2):84-91. PubMed ID: 20092910
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
    Maggio E, Peroglio Deiro A, Mete M, Sartore M, Polito A, Prigione G, Guerriero M, Pertile G.
    Ophthalmologica; 2020 Feb; 243(3):224-235. PubMed ID: 31905361
    [Abstract] [Full Text] [Related]

  • 11. Functional and structural outcome after vitrectomy combined with subretinal rtPA Injection with or without additional intravitreal Bevacizumab injection for submacular hemorrhages.
    Rickmann A, Paez LR, Della Volpe Waizel M, Bisorca-Gassendorf L, Schulz A, Vandebroek AC, Szurman P, Januschowski K.
    PLoS One; 2021 Feb; 16(4):e0250587. PubMed ID: 33930041
    [Abstract] [Full Text] [Related]

  • 12. Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.
    Thompson JT, Sjaarda RN.
    Trans Am Ophthalmol Soc; 2005 Feb; 103():98-107; discussion 107. PubMed ID: 17057793
    [Abstract] [Full Text] [Related]

  • 13. Successful treatment of acute subretinal hemorrhage in age-related macular degeneration by combined intravitreal injection of recombinant tissue plasminogen activator and gas.
    Hesse L, Kroll P.
    Adv Ther; 1997 Feb; 14(5):275-80. PubMed ID: 10174620
    [Abstract] [Full Text] [Related]

  • 14. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.
    Haupert CL, McCuen BW, Jaffe GJ, Steuer ER, Cox TA, Toth CA, Fekrat S, Postel EA.
    Am J Ophthalmol; 2001 Feb; 131(2):208-15. PubMed ID: 11228297
    [Abstract] [Full Text] [Related]

  • 15. Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration.
    Sacu S, Stifter E, Vécsei-Marlovits PV, Michels S, Schütze C, Prünte C, Schmidt-Erfurth U.
    Eye (Lond); 2009 Jun; 23(6):1404-10. PubMed ID: 18756282
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
    Hay SR, Madonna RJ.
    Optometry; 2000 Nov; 71(11):715-21. PubMed ID: 11101129
    [Abstract] [Full Text] [Related]

  • 17. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.
    Krepler K, Kruger A, Tittl M, Stur M, Wedrich A.
    Retina; 2000 Nov; 20(3):251-6. PubMed ID: 10872929
    [Abstract] [Full Text] [Related]

  • 18. Subretinal tissue plasminogen activator injection to treat submacular haemorrhage during age-related macular degeneration.
    Dewilde E, Delaere L, Vaninbroukx I, Van Calster J, Stalmans P.
    Acta Ophthalmol; 2014 Sep; 92(6):e497-8. PubMed ID: 24943231
    [No Abstract] [Full Text] [Related]

  • 19. [The intravitreal application of the tissue plasminogen activator in the treatment of submacular hemorrhage--a case report].
    Fric E, Sín M, Rehák M, Chrapek O, Simicák J, Fehák J.
    Cesk Slov Oftalmol; 2008 Nov; 64(6):237-40. PubMed ID: 19110965
    [Abstract] [Full Text] [Related]

  • 20. [Subretinal co-application of rtPA and bevacizumab for exudative AMD with submacular hemorrhage. Compatibility and clinical long-term results].
    Hillenkamp J, Klettner A, Puls S, Treumer F, Roider J.
    Ophthalmologe; 2012 Jul; 109(7):648-56. PubMed ID: 22752624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.